Sections
Log in
Top News
U.S. News World News Featured Voices
Odd News
Entertainment
Movies Music TV
Sports
Soccer NFL NBA MLB
Photos
News Entertainment Sports Features
More...
Defense Featured Science Health Video Archive Almanac
About Feedback Privacy Policy
About Feedback Privacy Policy
Search
Health News
Nov. 18, 2019 / 11:51 AM

Entresto, Corlanor are widely used, cost-effective options for heart failure, study finds

The number of Medicare beneficiaries prescribed sacubitril/valsartan increased from 35,423 in 2016 to 90,606 in 2017, a 156 percent increase. Photo by jorono/Pixabay
The number of Medicare beneficiaries prescribed sacubitril/valsartan increased from 35,423 in 2016 to 90,606 in 2017, a 156 percent increase. Photo by jorono/Pixabay


Nov. 18 (UPI) -- Two fairly new medications for heart failure have become staples for those who receive Medicare benefits and are "cost-effective" options, an analysis published Monday in the journal JAMA Cardiology has found.

The study sought to evaluate national patterns of use for sacubitril/valsartan -- marketed as Entresto and manufactured by Novartis -- and ivabradine -- marketed as Corlanor and manufactured by Amgen -- and associated spending on the two drugs within Medicare Part D. Both drugs were approved for the treatment of heart failure with reduced ejection fraction by the U.S. Food and Drug Administration in 2015.

The authors analyzed figures from the Medicare Part D Prescription Drug Event and Medicaid Utilization and Spending databases for 2016 and 2017. Overall, they found that the number of Medicare beneficiaries prescribed sacubitril/valsartan increased from 35,423 in 2016 to 90,606 in 2017, a 156 percent increase. The number of Medicare beneficiaries prescribed ivabradine increased from 15,856 to 23,213 over the same period, a 46 percent increase.

In all, in 2017, Medicare Part D spent $227 million and $7.3 million on sacubitril/valsartan and ivabradine, respectively, which equated to increases of 241 percent and 59 percent for each drug over 2016 spending. Still, annual Medicare per-beneficiary spending on sacubitril/valsartan and ivabradine was $2,512 and $2,400 -- well within what the authors describe as "spending thresholds that have been reported to be cost-effective."

Read More

Expensive device used in heart surgeries might pose dangers Cheap, older gout drug could be lifesaver after heart attack Study casts doubt on angioplasty, bypass for many heart patients
  • Topics
  • Food and Drug Administration

Latest Headlines

Three-quarters of U.S. teens who vape use nicotine, marijuana, or both
Health News // 1 hour ago
Three-quarters of U.S. teens who vape use nicotine, marijuana, or both
Dec. 16 (UPI) -- A new study in the American Journal of Preventive Medicine revealed that three-quarters of teens who vape use the e-cigarette devices to smoke not just nicotine products but marijuana as well.

'Prehab' before surgery helps speed seniors' recovery
Health News // 16 hours ago
'Prehab' before surgery helps speed seniors' recovery
"Training" for surgery can improve seniors' outcomes and reduce insurance costs, a new study says.

Indoor pollutants may raise allergy risk in toddlers
Health News // 16 hours ago
Indoor pollutants may raise allergy risk in toddlers
Toddlers have an increased risk of allergies if they are exposed to multiple indoor pollutants in their first years of life, a new study finds.

Premium changes, Medicaid expansion driving ACA enrollment drop
Health News // 2 days ago
Premium changes, Medicaid expansion driving ACA enrollment drop
Dec. 13 (UPI) -- Why have fewer Americans used the federal insurance exchange this year than in years past? Increased premiums for enrollees that receive subsidies, more states expanding Medicaid and expansion of non-ACA plans.

CDC: 1,300 Americans have died from flu so far this year
Health News // 2 days ago
CDC: 1,300 Americans have died from flu so far this year
Dec. 13 (UPI) -- More than 4,000 new cases of influenza were confirmed across the country this week as flu season shifts into high gear.

New study shakes up thinking on hormone replacement therapy
Health News // 2 days ago
New study shakes up thinking on hormone replacement therapy
The debate about postmenopausal hormone therapy and breast cancer risk may have turned muddier: A new study suggests that two different types of hormone therapy have opposite effects on women's long-term risk.

Liquid biopsy may predict breast cancer recurrence
Health News // 2 days ago
Liquid biopsy may predict breast cancer recurrence
Dec. 13 (UPI) -- A new tool could make it easier to predict whether early-stage triple-negative breast cancer will return following chemotherapy, according to results of a trial using a liquid biopsy to detect circulating tumor DNA.

Breast cancer drug found effective nearly six years after treatment
Health News // 2 days ago
Breast cancer drug found effective nearly six years after treatment
Dec. 13 -- Nearly six years after stopping a five-year regimen of the breast cancer drug anastrozole, women at high risk for breast cancer were 50 percent less likely to have been struck by the disease, new research shows.

Study: Secondhand smoke increases heart disease risk in children
Health News // 2 days ago
Study: Secondhand smoke increases heart disease risk in children
Dec. 13 -- Secondhand smoke can harm children's arteries, a new study warns, finding that smoke caused increased stiffness in the abdominal aortas of kids in the study.

Kids whose parents are depressed have different brains
Health News // 3 days ago
Kids whose parents are depressed have different brains
The brains of kids who have a high risk of depression because they have parents with depression are structurally different from other kids' brains, a new study finds.

Trending Stories

'Prehab' before surgery helps speed seniors' recovery
'Prehab' before surgery helps speed seniors' recovery
Indoor pollutants may raise allergy risk in toddlers
Indoor pollutants may raise allergy risk in toddlers
Sleepy nurses could affect patient care
Sleepy nurses could affect patient care
Three-quarters of U.S. teens who vape use nicotine, marijuana, or both
Three-quarters of U.S. teens who vape use nicotine, marijuana, or both
Liquid biopsy may predict breast cancer recurrence
Liquid biopsy may predict breast cancer recurrence

Photo Gallery

 
Hemingway watches, 'Dupont Emerald' on display at Christie's preview
Hemingway watches, 'Dupont Emerald' on display at Christie's preview

Latest News

Schumer requests Mulvaney, Bolton to testify in Senate's impeachment trial
U.S. nuclear envoy: No deadline on talks with North Korea
Three-quarters of U.S. teens who vape use nicotine, marijuana, or both
5 staffers to Democrat lawmaker Jeff Van Drew resign
3 bodies discovered at the Alamo
 
Back to Article
/
Back to top
About UPI Contact Feedback Advertisements Submit News Tips
Copyright © 2019 United Press International, Inc. All Rights Reserved.
Terms of UsePrivacy Policy